COVID-19 may trigger new diabetes, say experts

LONDON: COVID-19 may trigger the onset of diabetes in healthy people, and also cause severe complications in diabetic patients, according to an international group of 17 leading experts in the chronic condition.

Based on clinical observations made so far, the scientists, including Stephanie A. Amiel from King's College London in the UK, said there is a bi-directional relationship between COVID-19 and diabetes.

In a letter published in the New England Journal of Medicine, they explained that diabetes, on the one hand, is associated with increased risk of COVID-19 severity and mortality with 20 to 30 per cent of patients who died with the infectious disease reported to have diabetes.

On the other hand, the researchers said new-onset diabetes and atypical metabolic complications of preexisting diabetes -- including

life-threatening ones -- have been observed in people with COVID-19.

However, they said it is still unclear how SARS-COV-2, the virus that causes COVID-19, impacts diabetes.

Earlier studies had shown that the protein ACE-2 which binds to SARS-COV-2 and allows the virus to enter human cells is not only located in the

lungs, but also in organs and tissues involved in glucose metabolism such as the pancreas, the small intestine, the fat tissue, the liver and the kidney.

According to the researchers, by entering these tissues, the virus may cause multiple and complex dysfunctions of glucose metabolism.

The scientists believe it is possible that the novel coronavirus may alter glucose metabolism that could complicate the condition of preexisting diabetes or lead to new mechanisms of disease.

Based on previous research, they said virus infections can also precipitate type 1 diabetes - a chronic condition in which the pancreas produces little or no insulin.